De La Cruz, Lucy M <br/><br/>
Restoring anti-oncodriver Th1 responses with dendritic cell vaccines in HER2/neu-positive breast cancer: progress and potential.  [electronic resource] 

 -  Immunotherapy  10 2016 
 - 1219-32 p.  digital 
<br/><br/> Publication Type: Journal Article; Review; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1750-7448 
<br/><br/><label>Standard No.: </label>10.2217/imt-2016-0052  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Breast Neoplasms--immunology<br/>Cancer Vaccines--immunology<br/>Dendritic Cells--immunology<br/>Female<br/>Humans<br/>Immunotherapy--methods<br/>Lymphocyte Activation<br/>Neoadjuvant Therapy<br/>Receptor, ErbB-2--immunology<br/>Survival Analysis<br/>Th1 Cells--immunology<br/>Trastuzumab--therapeutic use